[Angiology in Rhythmology: What Should I know About Vascular Complications?]

Overview

Journal Herzschrittmacherther Elektrophysiol

Date 2025 Feb 3

PMID 39900809

Authors

Kristina Sonnenschein

Affiliations

Soon will be listed here.

Abstract

Both the performance of electrophysiological examinations and the implantation of cardiac devices (pacemakers, implantable cardioverter-defibrillator [ICDs], and cardiac resynchronization therapy defibrillator [CRT-D] systems) are associated with vascular punctures. This article provides an overview of possible vascular complications and their management from the perspective of angiology. The most common access site for invasive electrophysiological procedures is usually via the femoral veins and/or arteries. Puncture of the brachial vessels is a possible but rarely used alternative. For implantation of transvenous cardiac devices, access via the cephalic vein or axillary vein is used. The electrodes located in the venous vascular system represent a foreign material and increase the risk of thrombus formation in the affected vein. Punctures of the femoral vessels can lead to bleeding, thrombosis and the formation of arteriovenous fistulas or pseudoaneurysms (aneurysma spurium). Venous thromboses can occur postprocedurally. The correct puncture technique is essential to avoid complications. Ultrasound-guided puncture also significantly reduces the rate of vascular complications.

References

Foerschner L, Erhard N, Dorfmeister S, Telishevska M, Kottmaier M, Bourier F . Ultrasound-Guided Access Reduces Vascular Complications in Patients Undergoing Catheter Ablation for Cardiac Arrhythmias. J Clin Med. 2022; 11(22). PMC: 9696936. DOI: 10.3390/jcm11226766. View

Konstantinides S, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V . 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2019; 41(4):543-603. DOI: 10.1093/eurheartj/ehz405. View

van Es N, Coppens M, Schulman S, Middeldorp S, Buller H . Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014; 124(12):1968-75. DOI: 10.1182/blood-2014-04-571232. View

van der Hulle T, Kooiman J, den Exter P, Dekkers O, Klok F, Huisman M . Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. 2013; 12(3):320-8. DOI: 10.1111/jth.12485. View

Chen D, Sammel A, Jain P, Jepson N . Cardiologist operated ultrasound guided thrombin injection as a safe and efficacious first line treatment for iatrogenic femoral artery pseudoaneurysms. Heart Lung Circ. 2014; 24(2):165-72. DOI: 10.1016/j.hlc.2014.07.066. View

Burri H, Starck C, Auricchio A, Biffi M, Burri M, dAvila A . EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS),.... Europace. 2021; 23(7):983-1008. DOI: 10.1093/europace/euaa367. View

Ageno W, Haas S, Weitz J, Goldhaber S, Turpie A, Goto S . Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost. 2019; 119(8):1365-1372. DOI: 10.1055/s-0039-1688828. View

Houghton D, Casanegra A, Peterson L, Cochuyt J, Hodge D, Vlazny D . Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Am J Hematol. 2020; 95(7):817-823. DOI: 10.1002/ajh.25820. View

Davis L, Chik W, Kumar S, Sivagangabalan G, Thomas S, Denniss A . Axillary vein access using ultrasound guidance, Venography or Cephalic Cutdown-What is the optimal access technique for insertion of pacing leads?. J Arrhythm. 2021; 37(6):1506-1511. PMC: 8637085. DOI: 10.1002/joa3.12639. View

10.

Prandoni P, Bernardi E, Marchiori A, Lensing A, Prins M, Villalta S . The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ. 2004; 329(7464):484-5. PMC: 515197. DOI: 10.1136/bmj.38167.684444.3A. View

11.

Kovacs M, Kahn S, Rodger M, Anderson D, Andreou R, Mangel J . A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost. 2007; 5(8):1650-3. DOI: 10.1111/j.1538-7836.2007.02613.x. View

12.

Karabay O, Yetkin U, Onol H . Upper extremity deep vein thrombosis: clinical and treatment characteristics. J Int Med Res. 2004; 32(4):429-35. DOI: 10.1177/147323000403200413. View

13.

Rathbun S, Stoner J, Whitsett T . Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost. 2011; 9(10):1924-30. DOI: 10.1111/j.1538-7836.2011.04466.x. View

14.

Desjardins B, Hanley M, Steigner M, Aghayev A, Azene E, Bennett S . ACR Appropriateness Criteria® Suspected Upper Extremity Deep Vein Thrombosis. J Am Coll Radiol. 2020; 17(5S):S315-S322. DOI: 10.1016/j.jacr.2020.01.020. View

15.

Dronkers C, Klok F, Huisman M . Current and future perspectives in imaging of venous thromboembolism. J Thromb Haemost. 2016; 14(9):1696-710. DOI: 10.1111/jth.13403. View

16.

Zwicker J, Connolly G, Carrier M, Kamphuisen P, Lee A . Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014; 12(5):796-800. DOI: 10.1111/jth.12527. View